Anticoagulants Flashcards
aspirin
decreases thrombus risk in CAD and post- MI patients
inhibits COX/PLT aggregation
SE:asthma
thienopyridines
clopidogrel (Plavix)
ticlopidine (Ticlid)
these drugs block ADP receptors on platelets, to inhibit platelet aggregation
Role:
- aspirin intolerance
- history of MI or stroke
- PVD
- post-vascular intervention
Complications:
GI bleed
hemorrhage
Glycoprotein IIB/IIIa inhibitors
abciximab
tirofiban
eptifibatide
mechanism: inhibit platelet aggregation by binding to GPIIb/IIIa receptor
Role:
- unstable angina
- following coronary vessel intervention
- non-STEMI, in patients who are being managed medically
complications: hemorrhage
Adenosine re-uptake inhibitors
Dipyridamole (Aggrenox)
Role:
recent stroke
artificial heart valve replacement (with warfarin), but this is second line usually clopidogrel is used instead
Adverse effects:
HA
Heparin
Makes antithrombin more active
antithrombin inactivates thrombin and other coagulation factors, shutting down the body’s ability to make more fibrin clots
Role: post-op DVT prophylaxis dialysis (heparin flush) flush IV catheter decreases post- MI thrombus risk safer than warfarin during pregnancy
monitor with PTT
Side effect:
thrombocytopenia, heparin- induced
a state of hypercoagulability despite thrombocytopenia (low platelets)
In HIT, antibodies form that end up aggregating activated platelets and taking them out of circulation.
Low molecular weight heparins
enoxaparin
dalteparin
bind to factor Xa
prevent clot formation
used like heparin, but easier to administer because given sQ 2x qD instead of continuously, with weight-based dosing
can monitor with anti-factor Xa
Safest during preg
do not require monitoring with PTT
Direct thrombin inhibitors
argatroban
bivalidurin
role: anticoagulation in HIT
Fondaparinux acts by activating thrombin, and it can also be used to treat HIT (indirect thrombin inhibitor)
Direct factor Xa inhibitors
Riveroxaban
Apixiban
can be given orally
role: afib
post-op DVT prophylaxis
Direct thrombin inhibitors
Warfarin
inhibits Vit K dependent activation of factors 10,9,7,2,protein S, protein C
role: hypercoagulable syndromes atrial fibrillation artificial heart valves DVT/PE
adverse effects:
hemorrhage
drug interactions
teratogeniic
monitor with PT/INR
manage OD vitamin K (2-3 days), FFP
bridge with heparin
Streptokinase mechanism
cleaves fibrin clots
What anticoagulants are safe in pregnancy?
LMWH
unfractionated heparin